Kantarjian, H. M., Sekeres, M. A., Ribrag, V., Rousselot, P., Garcia-Manero, G., Jabbour, E. J., . . . Oliver, S. D. (2013). Phase I study assessing the safety and tolerability of barasertib (AZD1152) with low-dose cytosine arabinoside in elderly patients with AML.

Kantarjian, Hagop M., Mikkael A. Sekeres, Vincent Ribrag, Philippe Rousselot, Guillermo Garcia-Manero, Elias J. Jabbour, Kate Owen, Paul K. Stockman, und Stuart D. Oliver. Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-dose Cytosine Arabinoside in Elderly Patients With AML. 2013.

Kantarjian, Hagop M., et al. Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-dose Cytosine Arabinoside in Elderly Patients With AML. 2013.